BIT Analytical Instruments to Host Reception Featuring Stefan Messer of Messer Group, GmbH

Share Article

BIT Analytical Instruments (BIT Companies) will host a reception on July 17 at the convention of the American Association of Clinical Chemistry (AACC) in Los Angeles, CA. Making a special appearance at the reception will be Stefan Messer, CEO of Messer Group GmbH, and owner of Messer Conglomerate, the parent group to BIT Companies.

BIT Companies, (, will host a reception at the American Association of Clinical Chemistry (Booth #937) in Los Angeles, CA, USA on Tuesday, July 17 from 5:00-6:30pm. Featured at the reception will be Stefan Messer, owner and CEO of Messer Group GmbH, the parent company of BIT Companies: BIT Analytical Instruments, BIT MedTech, Source Scientific, BIT Technologies, BIT Japan and BIT C2 Diagnostics.

For more than 100 years, the name Messer has been associated with expertise in industrial gases, manufacturing and supplying a wide variety of gas mixtures in multiple global market segments. Messer Group GmbH is part of Messer World which employs more than 8400 people within seven companies specializing in engineering, industrial gas and medical industries in over 30 countries.

In 2012, Stefan Messer was honored for his admirable business achievements by being named “Family Entrepreneur of the Year” at the 2010 INTES Business Success Forum. In addition, Stefan Messer’s entrepreneurial achievements were recognized when he was awarded “Focus for Excellence, 2010.”

For over 35 years BIT Companies ( have provided services in the field of contract development and manufacturing as well as after-sales service for customers in the fields of medical, diagnostics, life science, and biotechnology. As a part of the financially strong Messer World, BIT Companies provide their systems solutions worldwide and in compliance with ISO 13485 and 9001 standards. As registered contract service providers to the FDA, BIT Companies meet the stringent regulations with regard to medical and complex medical technical products while simultaneously adhering to predefined design-to-cost and time-to-market targets.

BIT Companies ( include BIT Medtech in San Diego, CA, USA; Source Scientific, LLC in Irvine, California, USA; BIT Analytical Instruments Ludlow, Massachusetts USA; BIT Analytical Instruments GmbH in Schwalbach, Germany; BIT Technologies in Kunshan, China; BIT Japan Ltd. in Tokyo Japan; and BIT C2 Diagnostics in Montpellier, France.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brian Jarvis
Visit website